Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14218/JCTH.2014.00022 http://scihub22266oqcxt.onion/10.14218/JCTH.2014.00022 C4521245!4521245!26355652     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Transl+Hepatol 2014 ; 2 (3): 197-201 Nephropedia Template TP {{tp|p=26355652|t=2014. Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection |pdf=|usr=}}{{26355652}} gab.com Text Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection JO: J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=26355652 #FOAvip Hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide, with 75% of those affected distributed in the Asia-Pacific region. Approximately one million HBV-infected patients die of liver cirrhosis and hepatocellular carcinoma (HCC) each year. If left untreated, 6?20% of chronic hepatitis B (CHB) patients will develop cirrhosis over five years. The cumulative incidence of HBV-related cirrhosis, disease progression, and prognosis are closely associated with serum HBV DNA levels. Antiviral therapy in HBV-related cirrhosis has been documented by several long-term cohort studies to decrease disease progression to hepatic decompensation and HCC. The approval and availability of oral antiviral agents with better safety profiles has greatly improved the prognosis for HBV-related cirrhosis. Here, we discuss the significance of antiviral therapy for HBV-related cirrhosis and the management of HBV-related diseases in the future. Twit Text FOAVip Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection ????J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=26355652 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26355652 #FOAvip English Wikipedia <ref>{{Cite pmid|26355652}}</ref> Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection #MMPMID26355652 Lu LG J Clin Transl Hepatol 2014[Sep]; 2 (3): 197-201 PMID26355652show ga Hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide, with 75% of those affected distributed in the Asia-Pacific region. Approximately one million HBV-infected patients die of liver cirrhosis and hepatocellular carcinoma (HCC) each year. If left untreated, 6?20% of chronic hepatitis B (CHB) patients will develop cirrhosis over five years. The cumulative incidence of HBV-related cirrhosis, disease progression, and prognosis are closely associated with serum HBV DNA levels. Antiviral therapy in HBV-related cirrhosis has been documented by several long-term cohort studies to decrease disease progression to hepatic decompensation and HCC. The approval and availability of oral antiviral agents with better safety profiles has greatly improved the prognosis for HBV-related cirrhosis. Here, we discuss the significance of antiviral therapy for HBV-related cirrhosis and the management of HBV-related diseases in the future. äAntiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infe(epmc).pdf DeepDyve Pubget Overpricing